Aberrant expression of active leukotriene C4 synthase in CD16+ neutrophils from patients with chronic myeloid leukemia

Blood

Volumn 95, Issue 4, 2000, Pages 1456-1464

  Sjölinder, Mikael ^b   Stenke, Leif ^b   Näsman Glaser, Barbro ^b   Widell, Susanne ^b   Doucet, Johanne ^b   Jakobsson, Per Johan ^b   Lindgren, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; GLUTATHIONE TRANSFERASE; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4 SYNTHASE;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0343775672     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1456.004k06_1456_1464     Document Type: Article

References (66)

1. Turhan AG, Solary E, Vainchenker W, Dusanter-Fourt I. Molecular pathophysiology of chronic myelogenous leukemia. Hematol & Cell Ther. 1998; 40:217.
2. 4 in chronic myelogenous leukaemia but not in polythaemia vera. Br J Haematol. 1990;74:257.
3. Lindgren JÅ, Stenke L, Mansour M, et al. Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediat. 1993;6:313.
4. Samuelsson B, Dahlén S-E, Lindgren JÅ, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237:1171.
5. Claesson H-E, Dahlén S-E. Asthma and leukotrienes: antileukotrienes as novel antiasthmatic drugs. J Int Med. 1999;245:205.
6. 4 - interactions with granulocyte-macrophage colony-stimulating factor. Blood. 1993;80:352.
7. 4. Biochem Biophys Res Commun. 1985;131:579.
8. Miller AM, Cullen MK, Kobb SM, Weiner RS. Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J Lab Clin Med. 1989;113:355.
9. 4. Cancer Res. 1989;49:1138.
10. Snyder DS, Castro R, Desforges JF. Antiproliferative effects of lipoxygenase inhibitors on malignant human hemopoietic cell lines. Exp Hematol. 1989;17:6.
11. Khan MA, Hoffbrand AV, Mehta A, Wright F, Tahami F, Wickremasinge RG. MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Leukemia Res. 1993;17:759.
12. Anderson KM, Levin J, Jajeh A, Seed T, Harris JE. Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase. Prostaglandin Leuk Essent Fatty Acids. 1993;48:323.
13. Anderson KM, Seed T, Jajeh A, et al. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells. Anticancer Res. 1996;16:2589.
14. Mayer RJ, Marshall LA. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J. 1993;7:339.
15. Ford-Hutchinson AW, Gresser M, Young RN. 5-Lipoxygenase. Ann Rev Biochem. 1994;63:383.
16. 4 in inflammation. Crit Rev Immunol. 1990;10:1.
17. 4 synthase. J Lipid Med Cell Sign. 1995;12: 333.
18. Keppler D, Jedlitschky G, Leier I. Transport and metabolism of leukotrienes. In: Dahlén S-E ed. Adv Prostaglandin Thromboxane Leukotriene Res. Vol 22. New York, NY: Raven Press Ltd; 1994:83-89.
19. 4 and chemotherapeutic agents in membrane vesicles. J Biol Chem. 1996; 271:9675.
20. 4 export mechanism in human platelets -Possible involvement of multidrug resistence-associated protein 1. J Lipid Res. 1999;40:439.
21. Verhagen J, Bruynzeel PLB, Koedam JA, et al. Specific leukotriene formation by purified human eosinophils and neutrophils. FEBS Lett. 1984; 168:23.
22. 4. Biochem Pharmacol. 1987;36:3195.
23. Williams JD, Czop JK, Austen KF. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 1984;132:3034.
24. 4 to cysteinyl-containing leukotrienes by human platelets. Eur J Biochem. 1988;178:81.
25. 4. J Biol Chem. 1988;263:174.
26. 4 synthase in platelets and species distribution of the enzyme activity. Eur J Biochem. 1998;251:227.
27. 4 by transcellular biosynthesis. Proc Natl Acad Sci U S A. 1986;83:1349.
28. 4 from human polymorphonuclear leukocytes. J Biol Chem. 1996;271:17,944.
29. Palmantier RR, Rocheleau H, Laviolette M, Mancini JA, Borgeat P. Characteristics of leukotriene biosynthesis by human granulocytes in presence of plasma. Biochim Biophys Acta. 1998;1389:187.
30. 4 transfer. Trends Pharmacol Sci. 1993;14:351.
31. 4 synthase. Biochim Biophys Acta. 1995;1256:257.
32. 4. Proc Natl Acad Sci U S A. 1994;91:7663.
33. 4 synthase. Proc Natl Acad Sci USA. 1994;91:9745.
34. Jakobsson P-J, Morgenstern R, Mancini JA, Ford-Hutchinson AW, Persson B. Common structural features of MAPEG-A widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Science. 1999;8: 689.
35. 4 synthase. J Biol Chem. 1996;271:22,203.
36. Jakobsson P-J, Mancini JA, Riendeau D, Ford-Hutchinson AW. Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. J Biol Chem. 1997;272:22,934.
37. 4 synthase in neutrophilic HL-60 cells. Mol Pharmacol. 1994;45:1043.
38. 4 synthase activity and attenuates cysteinyl leukotriene production in an eosinophilic substrain of HL-60 cells. J Immunol. 1994;153: 776.
39. 4 synthase activity in human platelets. Eur J Biochem. 1995; 234:513.
40. 4 synthase activity in human granulocyle suspensions. FEBS Lett. 1995; 377:87.
41. 4 synthase. FEBS Lett. 1999;449:66.
42. 4-synthesis deficiency: a new inborn error of metabolism linked to a fatal developmental syndrome. Lancet. 1998;352:1514.
43. 1. Molec Med. 1996;2:637.
44. Penrose JF, Spector J, Baldasaro M, et al. Molecular cloning of the gene for human leukotriene c-4 synthase - organization, nucleotide sequence, and chromosomal localization to 5q35. J Biol Chem. 1996;271:11,356.
45. 4 synthase expression in the monocyte-likecell line, THP-1. J Immunol. 1999;162:1101.
46. Crump M, Keating A. Acute leukemia in adults. Cur Opin Hematol. 1995;2:247.
47. Scoggan KA, Nicholson DW, Ford-Hutchinson AW. Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells. Eur J Biochem. 1996;239:572.
48. 4 in different human tissues is attributable to distinct membrane bound biosynthetic enzymes. J Biol Chem. 1997; 272:10,182.
49. Böyum A. Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuculear cells by one centrifugation and of granulocytes by combing centrifugation and sedimentation at 1 g. Scan J Clin Lab Invest. 1968; 97(suppl 21):77.
50. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156.
51. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol. 1996;156:4859.
52. Moqbel R, Ying S, Barkans J, et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 1995;155:4939.
53. Nonaka M, Nonaka R, Woolley K, et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol. 1995;155:3234.
54. Haeggström JZ. Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis. Clin Rev Allergy Immunol. 1999; 17:111.
55. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Meth. 1991;145:105.
56. Kabutomori O, Iwatani Y, Koh T, Yanagihara T. CD16 antigen density on neutrophils in chronic myeloproliferative disorders. Am J Clin Pathol. 1997;107:661.
57. Schmitt E, Fassbender B, Beyreuther K, Spaeth E, Schwarzkopf R, Rude E. Characterization of a T cell-derived lymphokine that acts synergistically with IL 3 on the growth of murine mast cells and is identical with IL 4. Immunobiol. 1987;174:406.
58. 4 in the immune system. Int J Immunopharmacol. 1992;14:441.
59. Dunbar CE, Stewart FM. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood. 1992; 79:1107.
60. Cervantes F, Rozman C. Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects. Annals Hematol. 1994;69:99.
61. 4 synthase during the development of eosinophils in vitro from cord blood progenitors. Blood. 1996;88:4338.
62. 4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate. Br J Haematol. 1998;101:728.
63. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834.
64. Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Chronic myelogenous leukemia: molecular and cellular aspects. J Cancer Res & Clin One. 1998;124:643.
65. Samuelsson J. Impaired activation of phospholipase D in polycythaemia vera-implications for the pathogenesis of the disease? Leukemia & Lympnoma. 1995;19:21.
66. Jakobsson P-J, Thorén S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A. 1999;96:7220.